Showing 1 to 2 of 2 results


Common Pain Relievers Show Promise in Cancer Prevention and Treatment
Studies show common pain relievers like aspirin, ibuprofen, and diclofenac may prevent cancer recurrence by inhibiting the enzyme cyclooxygenase-1, reactivating T-cells to destroy micrometastases, with effectiveness varying across cancer types and patient genetic factors, although potential side eff...
Common Pain Relievers Show Promise in Cancer Prevention and Treatment
Studies show common pain relievers like aspirin, ibuprofen, and diclofenac may prevent cancer recurrence by inhibiting the enzyme cyclooxygenase-1, reactivating T-cells to destroy micrometastases, with effectiveness varying across cancer types and patient genetic factors, although potential side eff...
Progress
40% Bias Score

Inavolisib Improves Outcomes in Pik3ca-Mutated Breast Cancer
A clinical trial (Inavo120) demonstrated that inavolisib, combined with palbociclib and fulvestrant, significantly improved progression-free and overall survival in 325 patients with hormone receptor-positive, HER2-negative, Pik3ca-mutated breast cancer compared to the standard therapy; the FDA appr...

Inavolisib Improves Outcomes in Pik3ca-Mutated Breast Cancer
A clinical trial (Inavo120) demonstrated that inavolisib, combined with palbociclib and fulvestrant, significantly improved progression-free and overall survival in 325 patients with hormone receptor-positive, HER2-negative, Pik3ca-mutated breast cancer compared to the standard therapy; the FDA appr...
Progress
40% Bias Score
Showing 1 to 2 of 2 results